Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. . Neurology 2024;103:e209868.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology 2024;103:e209868.
PMID: 39432877